Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000267471, named "member RAS oncogene family pseudogene," is classified as a pseudogene related to the RAS family, which are well-known regulators of cell signaling, proliferation, and cancer when mutated. However, this locus does *not* encode an active or functional protein. Instead, like other pseudogenes, it may play a regulatory role at the RNA level, for example by competing with other RNAs for microRNA binding (the ceRNA mechanism), but there is no direct evidence that this specific pseudogene is involved in disease or is a viable therapeutic target[1][4]. As a result, it is not considered a receptor, enzyme, or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Member RAS oncogene family pseudogene.